advertising_left.gif     advertising_right.gif
logo_sub_sheet.gif
 
   
HomeSubscribeAdvertisingPast 3 IssuesStaff My AccountHelpContact



August 11, 2008 Issue Volume 70, Number 32
Lead Stories for this Issue
  • Covance R&D Deal Meshes With Lilly’s “FIPNet” Model
  • Advisory Committee Policy Allows Members With Financial Conflicts To Vote
  • Medco Personalized Medicine Research Shows “Real World” Promise – Frueh
    Go to this Issue >>

  • August 4, 2008 Issue Volume 70, Number 31
    Lead Stories for this Issue
  • FDA Draws Upon New Authority To Mandate Elements OF ESA Labeling
  • Roche’s Actemra Postmarket Safety Plan May Obviate Need For REMS
  • Academic Detailing Bill Could Be Interim Step To Comparative Effectiveness
    Go to this Issue >>

  • July 28, 2008 Issue Volume 70, Number 30
    Lead Stories for this Issue
  • Roche’s High Stakes Gambit For Genentech
  • Pipeline Dreams: GSK’s Witty Outlines Plans To Lower Phase III Attrition
  • Republican Strategy To Protect Part D Raises Risks For Pharma

    Go to this Issue >>

  • search within:
     


    HomeSubscribeAdvertisingPast 3 IssuesStaff My AccountHelpContact

      FDC Reports is the publisher of "The Pink Sheet"; "The Pink Sheet" DAILY; "The Gray Sheet"; FDAAdvisoryCommittee.com; "The Tan Sheet"; "The Rose Sheet"; Pharmaceutical Approvals Monthly; "The Gold Sheet"; "The Silver Sheet"; Health News Daily; PharmAsia News, an Elsevier company.